Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE | Able Laboratories | N-021105 DISCN | 2001-06-26 | 1 products |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
pain | EFO_0003843 | D010146 | R52 |
urological manifestations | — | D020924 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | — | — | 1 | 1 | — | 2 |
Urinary retention | D016055 | HP_0000016 | R33 | — | — | 1 | 1 | — | 2 |
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | — | — | — | 1 | — | 1 |
Urge urinary incontinence | D053202 | EFO_0006865 | N39.41 | — | — | — | 1 | — | 1 |
Urinary incontinence | D014549 | HP_0000020 | R32 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Dysuria | D053159 | EFO_0003901 | R30 | — | — | 2 | — | — | 2 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | 2 | — | — | 2 |
Postoperative pain | D010149 | — | G89.18 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 1 | — | — | — | 1 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 1 | — | — | — | 1 |
Aging | D000375 | GO_0007568 | R41.81 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cystoscopy | D003558 | — | — | — | — | — | — | 2 | 2 |
Pelvic organ prolapse | D056887 | EFO_0004710 | — | — | — | — | — | 1 | 1 |
Stress urinary incontinence | D014550 | HP_0010992 | — | — | — | — | — | 1 | 1 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 1 | 1 |
Nephrolithiasis | D053040 | — | N20.0 | — | — | — | — | 1 | 1 |
Kidney calculi | D007669 | EFO_0004253 | N20 | — | — | — | — | 1 | 1 |
Urolithiasis | D052878 | — | N20-N23 | — | — | — | — | 1 | 1 |
Ureteral calculi | D014514 | — | — | — | — | — | — | 1 | 1 |
Ureteral diseases | D014515 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Phenazopyridine |
INN | phenazopyridine |
Description | Phenazopyridine is a diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity. It has a role as a local anaesthetic, a non-narcotic analgesic, a carcinogenic agent and an anticoronaviral agent. It is a diaminopyridine and a monoazo compound. It is a conjugate base of a phenazopyridine(1+). |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Nc1ccc(/N=N/c2ccccc2)c(N)n1 |
PDB | — |
CAS-ID | 94-78-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1242 |
ChEBI ID | — |
PubChem CID | 4756 |
DrugBank | DB01438 |
UNII ID | K2J09EMJ52 (ChemIDplus, GSRS) |